 BOSTON, Dec. 18, 2020 GLOBE NEWSWIRE -- Atea Pharmaceuticals, Inc. Nasdaq: AVIR Atea, a clinical-stage biopharmaceutical company, today announced that it has been added to the Russell 2000 Index, effective December 21, 2020, as part of the indexs quarterly initial public offering IPO additions. 